MedTrace Logo

Metabolic Syndrome in Young Patients With Acute Lymphoblastic Leukemia in Remission

NCT00801346 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 224

Last updated 2017-04-21

No results posted yet for this study

Summary

RATIONALE: Gathering information about metabolic syndrome from young patients with acute lymphoblastic leukemia may help doctors learn more about the disease.

PURPOSE: This phase I trial is studying the metabolic syndrome in young patients with acute lymphoblastic leukemia in remission.

Conditions

  • Fatigue
  • Leukemia
  • Long-term Effects Secondary to Cancer Therapy in Children

Interventions

OTHER

laboratory biomarker analysis

OTHER

metabolic assessment

OTHER

questionnaire administration

PROCEDURE

assessment of therapy complications

PROCEDURE

fatigue assessment and management

PROCEDURE

quality-of-life assessment

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Vanderbilt University Medical Center

    lead OTHER

Principal Investigators

  • Adam J. Esbenshade, MD · Vanderbilt-Ingram Cancer Center

Eligibility

Min Age
1 Year
Max Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2016-04-30
Completion
2016-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00801346 on ClinicalTrials.gov